rs2243284

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000589.4(IL4):​c.361-1186G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.332 in 151,872 control chromosomes in the GnomAD database, including 11,587 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.33 ( 11587 hom., cov: 31)

Consequence

IL4
NM_000589.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0860

Publications

10 publications found
Variant links:
Genes affected
IL4 (HGNC:6014): (interleukin 4) The protein encoded by this gene is a pleiotropic cytokine produced by activated T cells. This cytokine is a ligand for interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activator of transcription, has been shown to play a central role in mediating the immune regulatory signal of this cytokine. This gene, IL3, IL5, IL13, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL13. This gene, IL13 and IL5 are found to be regulated coordinately by several long-range regulatory elements in an over 120 kilobase range on the chromosome. IL4 is considered an important cytokine for tissue repair, counterbalancing the effects of proinflammatory type 1 cytokines, however, it also promotes allergic airway inflammation. Moreover, IL-4, a type 2 cytokine, mediates and regulates a variety of human host responses such as allergic, anti-parasitic, wound healing, and acute inflammation. This cytokine has been reported to promote resolution of neutrophil-mediated acute lung injury. In an allergic response, IL-4 has an essential role in the production of allergen-specific immunoglobin (Ig) E. This pro-inflammatory cytokine has been observed to be increased in COVID-19 (Coronavirus disease 2019) patients, but is not necessarily associated with severe COVID-19 pathology. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.756 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL4NM_000589.4 linkc.361-1186G>A intron_variant Intron 3 of 3 ENST00000231449.7 NP_000580.1
IL4NM_172348.3 linkc.313-1186G>A intron_variant Intron 2 of 2 NP_758858.1
IL4NM_001354990.2 linkc.*51-1186G>A intron_variant Intron 4 of 4 NP_001341919.1
LOC105379176NR_134248.1 linkn.176+1154C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL4ENST00000231449.7 linkc.361-1186G>A intron_variant Intron 3 of 3 1 NM_000589.4 ENSP00000231449.2
IL4ENST00000350025.2 linkc.313-1186G>A intron_variant Intron 2 of 2 1 ENSP00000325190.3
IL4ENST00000622422.1 linkc.*51-1186G>A intron_variant Intron 4 of 4 1 ENSP00000480581.1

Frequencies

GnomAD3 genomes
AF:
0.331
AC:
50280
AN:
151754
Hom.:
11561
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.589
Gnomad AMI
AF:
0.0165
Gnomad AMR
AF:
0.337
Gnomad ASJ
AF:
0.206
Gnomad EAS
AF:
0.777
Gnomad SAS
AF:
0.194
Gnomad FIN
AF:
0.364
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.157
Gnomad OTH
AF:
0.290
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.332
AC:
50364
AN:
151872
Hom.:
11587
Cov.:
31
AF XY:
0.339
AC XY:
25168
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.590
AC:
24365
AN:
41326
American (AMR)
AF:
0.337
AC:
5144
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
716
AN:
3470
East Asian (EAS)
AF:
0.776
AC:
4007
AN:
5166
South Asian (SAS)
AF:
0.194
AC:
933
AN:
4820
European-Finnish (FIN)
AF:
0.364
AC:
3836
AN:
10550
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.157
AC:
10676
AN:
67968
Other (OTH)
AF:
0.293
AC:
617
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1383
2766
4148
5531
6914
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.266
Hom.:
913
Bravo
AF:
0.349
Asia WGS
AF:
0.486
AC:
1690
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.9
DANN
Benign
0.41
PhyloP100
-0.086
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2243284; hg19: chr5-132016992; API